A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

NCT06950034 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Myelomonocytic Leukemia
Chronic Myelomonocytic Leukemia (CMML)
Chronic Myelomonocytic Leukemia-1
Chronic Myelomonocytic Leukemia-2
Refractory Chronic Myelomonocytic Leukemia
CMML
Acute Myeloid Leukemia
Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia Post Cytotoxic Therapy
Acute Myeloid Leukemias
Refractory Acute Myeloid Leukemia (AML)
Acute Monocytic Leukemia

Interventions

BIOLOGICAL: STX-0712

Sponsor

Solu Therapeutics, Inc